Lianyungang Jinkang Hexin Pharmaceutical

Jinkang Hexin Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the research, development, and large-scale manufacturing of bioactive folate derivatives. The company is a global leader in the production of L-5-methyltetrahydrofolate calcium, marketed under the proprietary brand name Magnafolate®, which is a stable, C-crystalline form of the active metabolite of folic acid. Their products are widely utilized in the pharmaceutical, nutraceutical, and medical food industries to treat folate deficiency and manage conditions like hyperhomocysteinemia, particularly for individuals with MTHFR genetic polymorphisms. Jinkang Hexin maintains a robust intellectual property portfolio and holds a Drug Master File (DMF) with the US FDA, positioning itself as a key supplier in the international health ingredient market.